Group Therapy for Women Prisoners With Comorbid Substance Use and Depression
NCT ID: NCT00606996
Last Updated: 2025-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2006-07-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates
NCT02214667
Substance Abuse and Trauma in Incarcerated Women
NCT01413984
Colorado Women's TC Project
NCT00249561
Concurrent Treatment for Substance Dependent Individuals With Post-Traumatic Stress Disorder (PTSD)
NCT01365247
Motivation and Skills for Delta-9-tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail
NCT00506753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study tests the hypotheses that as adjuncts to prison SUD treatment, IPT-G, relative to psychoeducation on co-occurring disorders, will produce at least moderate effect sizes for:
* Reduction in the risk and severity of substance use relapse after release from prison
* Recovery from depressive disorder and reduction in depressive symptoms
* Improvement in social support and interpersonal functioning
* Reduction in the severity of legal problems during the 3 month follow-up period
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IPT-G
Group Interpersonal Psychotherapy
Group interpersonal psychotherapy (IPT-G)
PSYCHOED
Psychoeducation
Psychoeducation on co-occurring disorders (PSYCHOED)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group interpersonal psychotherapy (IPT-G)
Psychoeducation on co-occurring disorders (PSYCHOED)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current primary (non-substance-induced, as defined by the SCID) depressive disorder (major depressive or dysthymic disorder) after at least 4 weeks of prison SUD treatment and abstinence.
* A minimum Hamilton Depression score of 18 or higher, indicating moderate to severe depression.
* Depressive disorder at any time while not incarcerated.
* Substance use disorder one month prior to incarceration.
* Between 10 and 18 weeks away from release from prison.
Exclusion Criteria
* Lifetime criteria for a psychotic disorder
* Actively suicidal
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brown University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Jennifer Johnson
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer E. Johnson, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Psychiatry and Human Behavior, Brown University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Adult Correctional Institution
Cranston, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCT01831349
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.